Tag: inflammation

The Endocrine Society has officially announced Martin Reincke, MD, as the recipient of the 2026 Outstanding Scholarly Physician Laureate Award, recognizing his decades of transformative work in clinical endocrinology and his leadership in academic medicine. Dr. Reincke, a professor of endocrinology and the former chair of Medical Department IV at Ludwig-Maximilians University (LMU) Hospital in…

The field of clinical endocrinology is witnessing a paradigm shift as artificial intelligence begins to address some of the most complex diagnostic challenges in rare genetic conditions. Recent findings published in The Journal of Clinical Endocrinology & Metabolism (JCEM) highlight a significant breakthrough in the management of congenital disorders of adrenal steroidogenesis (CDAS), a group…

The therapeutic landscape for male reproductive health is witnessing a significant shift as new research presented at the ENDO 2026 annual meeting suggests that glucagon-like peptide-1 (GLP-1) receptor agonists may offer a viable pathway for restoring testosterone levels and enhancing sperm quality in men struggling with obesity. The study, spearheaded by Pratibha Natesh, MBBS, MRCP,…

Ascendis Pharma A/S, a biopharmaceutical company utilizing its proprietary TransCon technology to develop new treatments for rare diseases, announced comprehensive updates on August 6 regarding its clinical programs for achondroplasia and the commercial performance of its flagship growth hormone therapy in the United States. The cornerstone of this announcement was the release of topline Week…

At least one in 12 individuals who undergo bariatric surgery will develop a severe, recurring condition known as post-bariatric hypoglycemia (PBH), a complication that demands intensive medical intervention and carries a profound socioeconomic toll. According to a comprehensive multi-study analysis presented at the ENDO 2026 conference, this metabolic disorder remains one of the most significant…

The annual ENDO 2026 meeting in Chicago served as a premier stage for the next generation of endocrine researchers, highlighted by the highly anticipated Rising Star Power Talks. This year’s event, hosted by the Endocrine Society’s Trainee and Career Development Committee (TCDCC), showcased fifteen early-career and in-training members who presented high-impact research in a fast-paced,…

In an unprecedented move designed to dismantle the traditional silos of medical research, the Endocrine Society and Keystone Symposia have announced a strategic partnership to launch a series of high-level scientific meetings. This collaboration seeks to explore the complex intersections of hormone signaling with some of the most pressing health challenges of the 21st century,…

A comprehensive study published in the Journal of the Endocrine Society has established a significant correlation between exposure to phthalates—ubiquitous chemicals found in plastics, personal care products, and various consumer goods—and elevated blood pressure in pregnant women. This research adds to a growing body of evidence suggesting that environmental factors play a critical role in…

The annual ENDO 2026 meeting, hosted by the Endocrine Society, served as the backdrop for one of the most anticipated events in the field of hormone research: the Rising Star Power Talks. This year, the spotlight shone on Lila Dabill, a PhD candidate from Washington University in St. Louis, who secured the Basic Science award…

Amylyx Pharmaceuticals, Inc. has officially reported positive topline results from its pivotal Phase 3 LUCIDITY clinical trial, a study designed to evaluate the safety and efficacy of avexitide in patients suffering from post-bariatric hypoglycemia (PBH). This condition, which frequently follows Roux-en-Y gastric bypass (RYGB) surgery, currently lacks an FDA-approved pharmacological treatment, leaving a significant portion…